David Windley
Stock Analyst at Jefferies
(4.72)
# 720
Out of 4,993 analysts
806
Total ratings
59%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Reiterated: Hold | $16 → $31 | $31.29 | -0.93% | 8 | Sep 17, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | $515 → $560 | $624.20 | -10.29% | 36 | Sep 14, 2026 | |
| CI The Cigna Group | Downgraded: Hold | $330 → $307 | $274.47 | +11.85% | 65 | Aug 3, 2026 | |
| HUM Humana | Reiterated: Buy | $235 → $624 | $378.58 | +64.83% | 69 | Jul 22, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $391 → $450 | $409.31 | +9.94% | 78 | Jul 16, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $169.55 | +13.83% | 74 | Jun 25, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $225 | $279.01 | -19.36% | 75 | May 8, 2026 | |
| CNC Centene | Reiterated: Hold | $43 → $39 | $64.99 | -39.99% | 88 | Apr 20, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $160 → $139 | $197.80 | -29.73% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $340 → $373 | $377.56 | -1.21% | 73 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $18 | $21.51 | -18.64% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $295 | $361.78 | -18.46% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $255 | $269.88 | -5.51% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $18.70 | +4.28% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $9.5 | $20.02 | n/a | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.75 → $3 | $0.4776 | n/a | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $263 | $206.97 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $335 | $261.31 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $15 | $8.52 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $177 → $190 | $44.38 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 → $248 | $6.27 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $4.85 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.69 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $0.8731 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $290.82 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $0.8895 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $172.72 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $44.18 | n/a | 1 | Aug 27, 2009 |
Oscar Health
Sep 17, 2026
Reiterated: Hold
Price Target: $16 → $31
Current: $31.29
Upside: -0.93%
Medpace Holdings
Sep 14, 2026
Reiterated: Hold
Price Target: $515 → $560
Current: $624.20
Upside: -10.29%
The Cigna Group
Aug 3, 2026
Downgraded: Hold
Price Target: $330 → $307
Current: $274.47
Upside: +11.85%
Humana
Jul 22, 2026
Reiterated: Buy
Price Target: $235 → $624
Current: $378.58
Upside: +64.83%
Elevance Health
Jul 16, 2026
Reiterated: Buy
Price Target: $391 → $450
Current: $409.31
Upside: +9.94%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $169.55
Upside: +13.83%
Charles River Laboratories International
May 8, 2026
Reiterated: Buy
Price Target: $225
Current: $279.01
Upside: -19.36%
Centene
Apr 20, 2026
Reiterated: Hold
Price Target: $43 → $39
Current: $64.99
Upside: -39.99%
Molina Healthcare
Apr 20, 2026
Reiterated: Hold
Price Target: $160 → $139
Current: $197.80
Upside: -29.73%
UnitedHealth Group
Apr 20, 2026
Reiterated: Buy
Price Target: $340 → $373
Current: $377.56
Upside: -1.21%
Feb 10, 2026
Reiterated: Hold
Price Target: $21 → $18
Current: $21.51
Upside: -18.64%
Feb 10, 2026
Reiterated: Buy
Price Target: $365 → $295
Current: $361.78
Upside: -18.46%
Feb 6, 2026
Reiterated: Buy
Price Target: $225 → $255
Current: $269.88
Upside: -5.51%
Nov 20, 2025
Reiterated: Buy
Price Target: $16 → $20
Current: $18.70
Upside: +4.28%
Sep 8, 2025
Reiterated: Hold
Price Target: $21 → $9.5
Current: $20.02
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $2.75 → $3
Current: $0.4776
Upside: n/a
Jun 4, 2025
Reiterated: Hold
Price Target: $263
Current: $206.97
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $280 → $335
Current: $261.31
Upside: n/a
Apr 21, 2025
Reiterated: Hold
Price Target: $16 → $15
Current: $8.52
Upside: n/a
Apr 26, 2021
Reiterated: Buy
Price Target: $177 → $190
Current: $44.38
Upside: n/a
Feb 25, 2021
Reiterated: Hold
Price Target: $200 → $248
Current: $6.27
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $4.85
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $3.69
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $0.8731
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $290.82
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $0.8895
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $172.72
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $44.18
Upside: n/a